News
Zacks Investment Research on MSN3h
Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...
Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback